Evidence map›Paper›PMID 29980636›Full record

ReviewNeurology2018

Neurology outreach clinic for Huntington disease in Peru: Lessons for neurodegenerative diseases.

Anastasia Vishnevetsky, Maryenela Illanes-Manrique, Miguel Inca-Martinez, Karina Milla-Neyra, Elison Sarapura-Castro, Pilar Mazzetti, Mario Cornejo-Olivas

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Genetics and genomics in Peru: Clinical and research perspective.Molecular genetics & genomic medicine · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anastasia VishnevetskyFrom the Neurogenetics Research Center (A.V., M. Illanes-Manrique, M. Inca-Martinez, K.M.-N., E.S.-C., P.M., M.C.-O.), Instituto Nacional de Ciencias Neurológicas, Lima, Peru; NIH Northern Pacific Fogarty Global Health Fellow (A.V., M. Illanes-Manrique, E.S.-C.), Bethesda, MD; Partners Neurology Residency (A.V.), Boston, MA; and School of Medicine (P.M.), Universidad Nacional Mayor de San Marcos, Lima, Peru. staseyvi@gmail.com.
Maryenela Illanes-ManriqueFrom the Neurogenetics Research Center (A.V., M. Illanes-Manrique, M. Inca-Martinez, K.M.-N., E.S.-C., P.M., M.C.-O.), Instituto Nacional de Ciencias Neurológicas, Lima, Peru; NIH Northern Pacific Fogarty Global Health Fellow (A.V., M. Illanes-Manrique, E.S.-C.), Bethesda, MD; Partners Neurology Residency (A.V.), Boston, MA; and School of Medicine (P.M.), Universidad Nacional Mayor de San Marcos, Lima, Peru.
Miguel Inca-MartinezFrom the Neurogenetics Research Center (A.V., M. Illanes-Manrique, M. Inca-Martinez, K.M.-N., E.S.-C., P.M., M.C.-O.), Instituto Nacional de Ciencias Neurológicas, Lima, Peru; NIH Northern Pacific Fogarty Global Health Fellow (A.V., M. Illanes-Manrique, E.S.-C.), Bethesda, MD; Partners Neurology Residency (A.V.), Boston, MA; and School of Medicine (P.M.), Universidad Nacional Mayor de San Marcos, Lima, Peru.
Karina Milla-NeyraFrom the Neurogenetics Research Center (A.V., M. Illanes-Manrique, M. Inca-Martinez, K.M.-N., E.S.-C., P.M., M.C.-O.), Instituto Nacional de Ciencias Neurológicas, Lima, Peru; NIH Northern Pacific Fogarty Global Health Fellow (A.V., M. Illanes-Manrique, E.S.-C.), Bethesda, MD; Partners Neurology Residency (A.V.), Boston, MA; and School of Medicine (P.M.), Universidad Nacional Mayor de San Marcos, Lima, Peru.
Elison Sarapura-CastroFrom the Neurogenetics Research Center (A.V., M. Illanes-Manrique, M. Inca-Martinez, K.M.-N., E.S.-C., P.M., M.C.-O.), Instituto Nacional de Ciencias Neurológicas, Lima, Peru; NIH Northern Pacific Fogarty Global Health Fellow (A.V., M. Illanes-Manrique, E.S.-C.), Bethesda, MD; Partners Neurology Residency (A.V.), Boston, MA; and School of Medicine (P.M.), Universidad Nacional Mayor de San Marcos, Lima, Peru.
Pilar MazzettiFrom the Neurogenetics Research Center (A.V., M. Illanes-Manrique, M. Inca-Martinez, K.M.-N., E.S.-C., P.M., M.C.-O.), Instituto Nacional de Ciencias Neurológicas, Lima, Peru; NIH Northern Pacific Fogarty Global Health Fellow (A.V., M. Illanes-Manrique, E.S.-C.), Bethesda, MD; Partners Neurology Residency (A.V.), Boston, MA; and School of Medicine (P.M.), Universidad Nacional Mayor de San Marcos, Lima, Peru.
Mario Cornejo-OlivasFrom the Neurogenetics Research Center (A.V., M. Illanes-Manrique, M. Inca-Martinez, K.M.-N., E.S.-C., P.M., M.C.-O.), Instituto Nacional de Ciencias Neurológicas, Lima, Peru; NIH Northern Pacific Fogarty Global Health Fellow (A.V., M. Illanes-Manrique, E.S.-C.), Bethesda, MD; Partners Neurology Residency (A.V.), Boston, MA; and School of Medicine (P.M.), Universidad Nacional Mayor de San Marcos, Lima, Peru.

Funding

Northern/Pacific Universities Global Health Research Training ConsortiumR25TW009345 · FIC · UNIVERSITY OF WASHINGTON · PI KOLARS, JOSEPH C., NERURKAR, VIVEK RAMCHANDRA · 2012 to 2016
$5.9M
FIC NIH HHS R25 TW009345
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Ambulatory Care FacilitiesHealth ResourcesHumansHuntington DiseaseNeurodegenerative DiseasesNeurologyPeru

Identifiers

PMID29980636
PMCPMC6105046

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.